Effects of amlodipine and perindoprilate on the structure and function of mitochondria in ventricular cardiomyocytes during ischemia‐reperfusion in the pig

The aim of this study was to determine whether amlodipine and/or perindoprilate injected intravenously (iv) prior to ischemia exerted protective effects on mitochondria structural and functional alterations induced by ischemia and aggravated by reperfusion. Heart rate, the duration of monophasic action potentials (dMAP), peak of the time derivative of left ventricular pressure (LV dP/dt max), mitochondria structural and functional parameters in the left ventricle ischemic area were measured after 45‐min ischemia and 1‐min reperfusion in domestic pigs either untreated or pretreated with amlodipine, perindoprilate or amlodipine + perindoprilate. Ischemia‐reperfusion (I/R) induced tachycardia, reduced dMAP and LV dP/dt max, and causes alterations of mitochondria structural and functional parameters with decreased oxygen consumption, increased reactive oxygen species production and reduced calcium retention capacity (CRC) with opening of mitochondrial permeability transition pores. This opening is mainly due to oxidative stress and calcium overload and seems to be the pivotal event in cell death after I/R. No drug treatment changed haemodynamic and electrophysiological parameters, but amlodipine and perindoprilate, either alone or combined, prevented mitochondrial alterations but only partially. The preservation of mitochondrial structure and functions reported in our study probably plays an important role in preventing calcium overload and mPTP opening during myocardial I/R by a specially increased CRC, which can explain their cardioprotective effects.

[1]  Xian-Liang Tang,et al.  Cardiac myocyte-specific transgenic ecSOD targets mitochondria to protect against Ca2+ induced permeability transition , 2013, Front. Physiol..

[2]  P. Lévy,et al.  Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia , 2013, Fundamental & clinical pharmacology.

[3]  P. Chevalier,et al.  Influence of ischemia and myocardial reperfusion kinetics on the structure and functions of mitochondria in the pig , 2012 .

[4]  J. Zweier,et al.  Targeting calcium transport in ischaemic heart disease. , 2009, Cardiovascular research.

[5]  Xiaodong Sun,et al.  Protective Effect of Perindopril on Diabetic Retinopathy Is Associated With Decreased Vascular Endothelial Growth Factor–to–Pigment Epithelium–Derived Factor Ratio , 2009, Diabetes.

[6]  Wahi Arun Kumar,et al.  Protective role of the calcium channel blocker amlodipine against mitochondrial injury in ischemia and reperfusion injury of rat liver , 2008, Acta pharmaceutica.

[7]  E. Omerovic,et al.  In vivo effects of myocardial creatine depletion on left ventricular function morphology and lipid metabolism: study in a mouse model. , 2008, Journal of cardiac failure.

[8]  R. Daoust,et al.  beta-Blockers for the treatment of cardiac arrest from ventricular fibrillation? , 2007, Resuscitation.

[9]  T. Vanden Hoek,et al.  Nitric oxide during ischemia attenuates oxidant stress and cell death during ischemia and reperfusion in cardiomyocytes. , 2007, Free radical biology & medicine.

[10]  N. Dhalla,et al.  Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease , 2007, Journal of cardiovascular medicine.

[11]  N. Dhalla,et al.  Role of oxidative stress in alterations of mitochondrial function in ischemic-reperfused hearts. , 2007, American journal of physiology. Heart and circulatory physiology.

[12]  C. Hoppel,et al.  Reversible Blockade of Electron Transport during Ischemia Protects Mitochondria and Decreases Myocardial Injury following Reperfusion , 2006, Journal of Pharmacology and Experimental Therapeutics.

[13]  L. Monassier,et al.  ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. , 2006, Journal of applied physiology.

[14]  P. Ping,et al.  Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. , 2005, American journal of physiology. Heart and circulatory physiology.

[15]  A. Uysal,et al.  Amlodipine and glutathione cycle in hypercholesterolaemia , 2004, Acta cardiologica.

[16]  Charles L. Hoppel,et al.  Production of Reactive Oxygen Species by Mitochondria , 2003, Journal of Biological Chemistry.

[17]  D. Yellon,et al.  Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. , 2003, Journal of molecular and cellular cardiology.

[18]  L. Rydén,et al.  Pharmacological possibilities for protection against myocardial reperfusion injury. , 2002, Cardiovascular research.

[19]  C. Hoppel,et al.  Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure. , 2001, Journal of molecular and cellular cardiology.

[20]  M. Crompton Mitochondrial intermembrane junctional complexes and their role in cell death , 2000, The Journal of physiology.

[21]  L. Becker,et al.  Generation of superoxide in cardiomyocytes during ischemia before reperfusion. , 1999, American journal of physiology. Heart and circulatory physiology.

[22]  B. Lucchesi,et al.  Mechanisms of myocardial reperfusion injury. , 1999, The Annals of thoracic surgery.

[23]  S. Dhein,et al.  Amlodipine Releases Nitric Oxide From Canine Coronary Microvessels: An Unexpected Mechanism of Action of a Calcium Channel–Blocking Agent , 1999 .

[24]  B. F. Becker,et al.  Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[25]  M Crompton,et al.  The mitochondrial permeability transition pore and its role in cell death. , 1999, The Biochemical journal.

[26]  E. Marbán,et al.  Molecular and cellular mechanisms of myocardial stunning. , 1999, Physiological reviews.

[27]  G. Wetscher,et al.  Interrelationship between cellular calcium homeostasis and free radical generation in myocardial reperfusion injury. , 1997, Chemico-biological interactions.

[28]  S. Maxwell,et al.  Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. , 1997, International journal of cardiology.

[29]  D. Frassati,et al.  Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes. , 1996, Canadian journal of physiology and pharmacology.

[30]  W. V. van Gilst,et al.  Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors. , 1993, The Canadian journal of cardiology.

[31]  W. Linz,et al.  Role of Bradykinin in the Cardiac Effects of Angiotensin‐Converting Enzyme Inhibitors , 1992, Journal of cardiovascular pharmacology.

[32]  K. Bel,et al.  The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs. , 1992, Journal of cardiovascular pharmacology.

[33]  L. Opie,et al.  Protons in ischemia: where do they come from; where do they go to? , 1991, Journal of molecular and cellular cardiology.

[34]  V. P. Chacko,et al.  Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning? , 1990, Circulation research.

[35]  M. A. Matlib,et al.  Protection of regional mechanics and mitochondrial oxidative phosphorylation by amlodipine in transiently ischemic myocardium. , 1989, The American journal of cardiology.

[36]  Xian-Liang Tang,et al.  Cardiac myocyte-specific transgenic ecSOD targets mitochondria to protect against Ca 2+ induced , 2013 .

[37]  A. Reichenbach,et al.  Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats. , 2011, Experimental eye research.

[38]  Gen-jie Ke,et al.  The Protective Effect of Perindopril on Diabetic Retinopathy is Associated with Decreased VEGF/PEDF Ratio: Involvement of a Mitochondria-ROS Pathway , 2009 .

[39]  C. Hoppel,et al.  Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. , 2007, American journal of physiology. Cell physiology.

[40]  L. Becker Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.

[41]  M. Trumbore,et al.  [Membrane biophysical interaction of amlodipine and antioxidant properties]. , 2000, Drugs.

[42]  Mark W. Trumbore,et al.  Interactions biophysiques membranaires de l???amlodipine et propri??t??s antioxydantes , 2000 .

[43]  R. Bolli,et al.  Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview. , 1993, Basic research in cardiology.

[44]  R. Jennings,et al.  High energy phosphates, anaerobic glycolysis and irreversibility in ischemia. , 1983, Advances in experimental medicine and biology.